EVOLUS talks about its partnership with SYMATESE at IMCAS

At the Worldwide IMCAS TRIBUNE round table on toxins, moderated by Dr. Benjamin Ascher and Natalene Hoepffner, on Friday February 2, 2024 in Paris, David Moatazedi, CEO of EVOLUS welcomed the partnership set up with SYMATESE at the beginning of May 2023 for the US market, then extended to Europe at the end of December 2023 concerning the distribution of our future range of dermal fillers under the EVOLYSSE^TM brand in the US and ESTYME^® FILLERS in Europe.